Abstract:AimsCopy number variant-sequencing (CNV-seq) and exome sequencing (ES) have been used as powerful tools in understanding the role of genetic variants in congenital heart diseases (CHDs). A few previous large cohort studies have utilized CNV-seq and ES to investigate prenatally diagnosed CHD. Here, we sought to determine the value of CNV-seq and ES for genetic evaluation of foetal CHDs. Methods and resultsWe recruited 398 pregnant women diagnosed with CHDs between 8 January 2017 and 30 November 2020. CNV-seq and ES were performed on foetal and parent samples. CHD cases were classified following the guidelines of the International Paediatric and Congenital Cardiac Code and the Tenth and Eleventh Revisions of the International Classification of Diseases. Data on aneuploids (AUP), pathogenic CNVs (pCNVs), and single nucleotide variants (SNVs) were collected and compared, following appropriate procedures. We identified genetic abnormalities in 129 (32.41%) foetuses. These abnormalities included AUP (10.80%), pCNVs (13.32%), and SNVs (8.04%). ES analysis yielded higher SNVs in cases without AUP or pCNVs. Non-isolated CHDs were associated with higher genetic abnormalities than isolated CHDs, mainly due to AUP differences between the two groups. The prevalence of genetic defects was the highest in foetuses with atrioventricular septal defects (AVSD), left ventricular outflow tract obstruction (LVOTO), and conotruncal defects (CTD). AVSD and anomalies of atrioventricular junctions and valves were associated with AUP abnormalities. CTD, anomalies of extrapericardial arterial trunks, and anomalies of the ventricular outflow tracts were the most common CHD categories diagnosed using CNVs. The most common CHDs associated with single ventricle (SV) abnormalities were heterotaxy (Hex) (14.89%), LVOTO (14.58%), and ventricular septal defect (VSD) (26.67%, 4/15). Although the ES yields were higher than CNV-seq for VSD (44.4%, 4/9), LVOTO (20%, 7/35), Hex (14.89%, 7/47), and CTD (9.1%, 11/121), its diagnostic yield did not increase for SV (6.7%, 1/15), AVSD (3.8%, 1/26), or right ventricular obstruction defects (2.6%, 1/38). The most common mutations were observed in KMT2D, CHD7, and NOTCH1. ConclusionsTo our knowledge, this is the largest cohort study to investigate the incidence of SNVs using ES in foetal CHD. CNV-seq and ES identified genetic abnormalities in nearly 1/3 of foetal CHD cases. Thus, CNV-seq and ES can provide clinically relevant information for pregnancy management.

OC11.07: Prenatal identification of atrioventricular septal defect and associated genomic abnormality by fetal echocardiography and whole-genome sequencing

Prenatal genetic diagnosis associated with fetal ventricular septal defect: an assessment based on chromosomal microarray analysis and exome sequencing

Analysis of genetic testing in fetuses with congenital heart disease of single atria and/or single ventricle in a Chinese prenatal cohort

OP18.05: Complete Atrioventricular Septal Defect: Prenatal Diagnosis with Fetal Echocardiography, Classification and Associated Malformations

Revisiting Atrioventricular Septal Defects: Exploring Chromosomal Abnormalities, Cardiac and Extracardiac Anomalies in a Contemporary Prenatal Cohort

Genetic aetiology distribution of 398 foetuses with congenital heart disease in the prenatal setting

The Analysis of Prenatal Diagnosis of Congenital Atrioventricular Septal Defect with the Related Factors

Prenatal finding of isolated ventricular septal defect: genetic association, outcomes and counseling

P01.03: Fetal Echocardiographic Features and Whole‐exome Sequencing Results of Ventricular Non‐compaction Cardiomyopathy

Agenesis of the Ductus Venosus and Its Association With Genetic Abnormalities

Genomic insights into prenatal diagnosis of congenital heart defects: value of CNV-seq and WES in clinical practice

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

OP01.09: Finding the Genomic Bases of Ultrasound‐detected Fetal Anomalies in First Trimester by Whole‐genome Sequencing

The Prenatal Diagnosis of Aortopulmonary Window by Fetal Echocardiography

Diagnostic Value of Chromosomal Microarray Analysis for Fetal Congenital Heart Defects with Different Cardiac Phenotypes and Extracardiac Abnormalities

P01.02: Frequency of 22q11 microdeletion syndrome in fetuses with conotruncal heart disease: Poster discussion hub abstracts

Simultaneous CNV-seq and WES: an Effective Strategy for Molecular Diagnosis of Unexplained Fetal Structural Anomalies

[Whole Exome Sequencing Analysis of 37 Fetuses with Cardiac Abnormalities].

Clinical efficiency of simultaneous CNV-seq and whole-exome sequencing for testing fetal structural anomalies

Relationship between diagnosis of conus arteriosus malformation and genetic diagnosis results in fetal cardiac axis abnormalities by echocardiography during middle pregnancy

Is Genomic Screening Necessary for Fetuses Who Suffer Moderate to Severe Tricuspid Regurgitation? A Case Report